ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Osler W, 1885. The Gulstonian lectures, on malignant endocarditis. BMJ 1: 467–470.
-
2.
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JLESC Committee for Practice Guidelines, 2009. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30: 2369–2413.
-
3.
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CHInternational Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators, 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169: 463–473.
-
4.
Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch FAssociation pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group, 2002. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288: 75–81.
-
5.
Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen BAEPEI Study Group, 2012. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 59: 1968–1976.
-
6.
Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen BAEPEI Study Group, 2012. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54: 1230–1239.
-
7.
Thuny F, Grisoli D, Collart F, Habib G, Raoult D, 2012. Management of infective endocarditis: challenges and perspectives. Lancet 379: 965–975.
-
8.
Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, Tleyjeh IM, 2014. Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart 9: 131–143.
-
9.
Cahill TJ, Prendergast BD, 2016. Infective endocarditis. Lancet 387: 882–893.
-
10.
Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla FAEPEI Study Group, 2011. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 32: 2003–2015.
-
11.
Hoen B, Duval X, 2013. Clinical practice. Infective endocarditis. N Engl J Med 368: 1425–1433.
-
12.
Delahaye F, Chu VH, Altclas J, Barsic B, Delahaye A, Freiberger T, Gordon DL, Hannan MM, Hoen B, Kanj SS, Lejko-Zupanc T, Mestres CA, Pachirat O, Pappas P, Lamas C, Selton-Suty C, Tan R, Tattevin P, Wang AInternational Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators, 2015. One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol 178: 117–123.
-
13.
Munoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, Fariñas MC, Cobo Belaustegui M, Mestres C, Llinares P, Goenaga M, Navas E, Oteo JA, Tarabini P, Bouza ESpanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES), 2015. Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort Study. Medicine (Baltimore) 94: e1816.
-
14.
Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr, 2002. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162: 90–94.
-
15.
Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O’Boyle C, Danila RN, Lynfield R, 2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976–2984.
-
16.
Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer ASInvestigators ICE, 2005. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293: 3012–3021.
-
17.
Le Moing V, Alla F, Doco-Lecompte T, Delahaye F, Piroth L, Chirouze C, Tattevin P, Lavigne JP, Erpelding ML, Hoen B, Vandenesch F, Duval XVIRSTA Study Group, 2015. Staphylococcus aureus bloodstream infection and endocarditis: a prospective cohort study. PLoS One 10: e0127385.
-
18.
Cabell CH, Abrutyn E, 2002. Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am 16: 255–272 vii.
-
19.
Letaief A, Boughzala E, Kaabia N, Ernez S, Abid F, Ben Chaabane T, Ben Jemaa M, Boujnah R, Chakroun M, Daoud M, Gaha R, Kafsi N, Khalfallah A, Slimane L, Zaouali M, 2007. Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis 11: 430–433.
-
20.
Nkomo VT, 2007. Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart 93: 1510–1519.
-
21.
Nunes MC, Gelape CL, Ferrari TC, 2010. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis 14: e394–e398.
-
22.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR, 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30: 633–638.
-
23.
Bach JF, Chalons S, Forier E, Elana G, Jouanelle J, Kayemba S, Delbois D, Mosser A, Saint-Aime C, Berchel C, 1996. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 347: 644–648.
-
24.
Garcia-Granja PE, Lopez J, Vilacosta I, Ortiz-Bautista C, Sevilla T, Olmos C, Sarriá C, Ferrera C, Gómez I, Román JA, 2015. Polymicrobial infective endocarditis: clinical features and prognosis. Medicine (Baltimore) 94: e2000.
-
25.
Coard KC, Skeete DH, 2003. Infective endocarditis at the University Hospital of the West Indies. A revisit. West Indian Med J 52: 235–239.
-
26.
Grangier C, Debin M, Ardillon V, Mahamat A, Fournier PE, Simonnet C, Guillot G, Louvel D, Ravachol F, Perenhou V, Queuche F, Legrand E, Djossou F, Quénel P, Morvan J, Meynard JB, 2009. Epidémiologie de la fièvre Q en Guyane, 1990–2006. Bulletin de Veille Sanitaire n°10 2009: 2–4.
-
27.
Edouard S, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D, 2014. Comparison between emerging Q fever in French Guiana and endemic Q fever in Marseille, France. Am J Trop Med Hyg 90: 915–919.
-
28.
Eldin C, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D, 2014. Q fever in French Guiana. Am J Trop Med Hyg 91: 771–776.
-
29.
da Costa PS, Brigatte ME, Greco DB, 2005. Antibodies to Rickettsia rickettsii, Rickettsia typhi, Coxiella burnetii, Bartonella henselae, Bartonella quintana, and Ehrlichia chaffeensis among healthy population in Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 100: 853–859.
-
30.
Lamas CC, Mares-Guia MA, Rozental T, Moreira N, Favacho AR, Barreira J, Guterres A, Bóia MN, de Lemos ER, 2010. Bartonella spp. infection in HIV positive individuals, their pets and ectoparasites in Rio de Janeiro, Brazil: serological and molecular study. Acta Trop 115: 137–141.
-
31.
Frankel D, Richet H, Renvoise A, Raoult D, 2011. Q fever in France, 1985–2009. Emerg Infect Dis 17: 350–356.
-
32.
Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, Branger S, Gouriet F, Imbert G, Bothello E, Collart F, Habib G, 2005. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43: 5238–5242.
-
33.
Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W, 2001. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 32: 50–62.
-
34.
Bhatti S, Vilenski L, Tight R, Smego RA Jr, 2005. Histoplasma endocarditis: clinical and mycologic features and outcomes. J Infect 51: 2–9.
-
35.
Kauffman CA, 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115–132.
-
36.
Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH, 2007. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 44: 364–372.
-
37.
Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM, 2007. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 115: 1721–1728.
-
38.
Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A, 2011. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 306: 2239–2247.
-
39.
Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW, 2012. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366: 2466–2473.
-
40.
Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, Poyart C, Alla F, Cambau E, Tattevin P, Chirouze C, Obadia JF, Duval X, Hoen BAEPEI Study Group, 2016. Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37: 840–848.
-
41.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Reviewers Document, Erol Ç, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM, 2015. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 36: 3075–3128.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 419 | 272 | 15 |
| Full Text Views | 413 | 9 | 0 |
| PDF Downloads | 96 | 12 | 0 |
Infective Endocarditis in French West Indies: A 13-Year Observational Study
Elisabeth Fernandes
Elisabeth Fernandes
Department of Infectious Diseases, Medicine B, Hospital of Basse Terre, Guadeloupe, France;
Search for other papers by Elisabeth Fernandes in
Current site
Google Scholar
PubMed
Search for other papers by Elisabeth Fernandes in
Current site
Google Scholar
PubMed
Claude Olive
Claude Olive
Laboratory of Bacteriology, University Hospital of Martinique, Fort-de-France, France;
Université des Antilles, EA 4537, Fort-de-France, France;
Search for other papers by Claude Olive in
Current site
Google Scholar
PubMed
Université des Antilles, EA 4537, Fort-de-France, France;
Search for other papers by Claude Olive in
Current site
Google Scholar
PubMed
Jocelyn Inamo
Jocelyn Inamo
Department of Cardiology, University Hospital of Martinique, Fort-de-France, France;
Search for other papers by Jocelyn Inamo in
Current site
Google Scholar
PubMed
Search for other papers by Jocelyn Inamo in
Current site
Google Scholar
PubMed
François Roques
François Roques
Department of Thoracic and Cardiovascular Surgery, University Hospital of Martinique, Fort-de-France, France;
Search for other papers by François Roques in
Current site
Google Scholar
PubMed
Search for other papers by François Roques in
Current site
Google Scholar
PubMed
André Cabié
André Cabié
Université des Antilles, EA 4537, Fort-de-France, France;
INSERM, CIC1424, Cayenne, France;
Department of Infectious Diseases, University Hospital of Martinique, Fort-de-France, France
Search for other papers by André Cabié in
Current site
Google Scholar
PubMed
INSERM, CIC1424, Cayenne, France;
Department of Infectious Diseases, University Hospital of Martinique, Fort-de-France, France
Search for other papers by André Cabié in
Current site
Google Scholar
PubMed
Patrick Hochedez
Patrick Hochedez
Université des Antilles, EA 4537, Fort-de-France, France;
Department of Infectious Diseases, University Hospital of Martinique, Fort-de-France, France
Search for other papers by Patrick Hochedez in
Current site
Google Scholar
PubMed
Department of Infectious Diseases, University Hospital of Martinique, Fort-de-France, France
Search for other papers by Patrick Hochedez in
Current site
Google Scholar
PubMed
We conducted an observational study to describe the characteristics of infective endocarditis (IE) in French West Indies (FWI) and to identify variables associated with in-hospital case fatality. The records of the patients admitted for IE to the University Hospital of Martinique between 2000 and 2012 were collected using an electronic case report form. Only Duke-Li definite cases were considered for this analysis. Variables associated with in-hospital mortality were tested using univariate logistic regression analysis. The analysis included 201 patients (median age 58 years, sex ratio: two males to one female). There was no previously known heart disease in 45.8%, a prosthetic valve in 21.4%, and previously known native valve disease in 32.8% of the cases. Community-acquired IE represented 59.7% of all cases, health-care-associated IE represented 38.3% and injection-drug-use-acquired IE represented 1.5%. Locations of IE were distributed as follows: 42.3% were mitral valve IE, 34.8% were aortic valve IE, and 7% were right-sided IE. Microorganisms recovered from blood cultures included 30.4% streptococci, 28.9% staphylococci, and 5% enterococci. Blood cultures were negative in 20.9% of the cases. Surgical treatment was performed in 53% of the patients. In-hospital case fatality rate was 19%. Advanced age, Staphylococcus aureus IE, and health-care-associated IE were associated with in-hospital case fatality. The epidemiological and microbiological profile of IE in FWI is in between those observed in developed countries and developing countries: patients were younger, blood cultures were more frequently negative, and IE due to group D streptococci and enterococci were less common than in industrialized countries.
Author Notes
Authors’ addresses: Elisabeth Fernandes, Department of Infectious Diseases, Medicine B, Hospital of Basse Terre, Guadeloupe, France, E-mails: fernandes.elisabeth@free.fr or elisabeth.fernandes@ch-labasseterre.fr. Claude Olive, Laboratory of Bacteriology, University Hospital of Martinique, Fort-de-France, France, E-mail: claude.olive@chu-fortdefrance.fr. Jocelyn Inamo, Department of Cardiology, University Hospital of Martinique, Fort-de-France, France, E-mail: jocelyn.inamo@chu-fortdefrance.fr. François Roques, Department of Thoracic and Cardiovascular Surgery, University Hospital of Martinique, Fort-de-France, France, E-mail: francois.roques@chu-fortdefrance.fr. André Cabié and Patrick Hochedez, Department of Infectious Diseases, University Hospital of Martinique, Fort-de-France, France, E-mails: andre.cabie@chu-fortdefrance.fr and patrick.hochedez@chu-fortdefrance.fr.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Osler W, 1885. The Gulstonian lectures, on malignant endocarditis. BMJ 1: 467–470.
-
2.
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JLESC Committee for Practice Guidelines, 2009. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30: 2369–2413.
-
3.
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CHInternational Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators, 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169: 463–473.
-
4.
Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch FAssociation pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group, 2002. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288: 75–81.
-
5.
Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen BAEPEI Study Group, 2012. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 59: 1968–1976.
-
6.
Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen BAEPEI Study Group, 2012. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54: 1230–1239.
-
7.
Thuny F, Grisoli D, Collart F, Habib G, Raoult D, 2012. Management of infective endocarditis: challenges and perspectives. Lancet 379: 965–975.
-
8.
Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, Tleyjeh IM, 2014. Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart 9: 131–143.
-
9.
Cahill TJ, Prendergast BD, 2016. Infective endocarditis. Lancet 387: 882–893.
-
10.
Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla FAEPEI Study Group, 2011. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 32: 2003–2015.
-
11.
Hoen B, Duval X, 2013. Clinical practice. Infective endocarditis. N Engl J Med 368: 1425–1433.
-
12.
Delahaye F, Chu VH, Altclas J, Barsic B, Delahaye A, Freiberger T, Gordon DL, Hannan MM, Hoen B, Kanj SS, Lejko-Zupanc T, Mestres CA, Pachirat O, Pappas P, Lamas C, Selton-Suty C, Tan R, Tattevin P, Wang AInternational Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators, 2015. One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol 178: 117–123.
-
13.
Munoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, Fariñas MC, Cobo Belaustegui M, Mestres C, Llinares P, Goenaga M, Navas E, Oteo JA, Tarabini P, Bouza ESpanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES), 2015. Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort Study. Medicine (Baltimore) 94: e1816.
-
14.
Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr, 2002. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162: 90–94.
-
15.
Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O’Boyle C, Danila RN, Lynfield R, 2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976–2984.
-
16.
Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer ASInvestigators ICE, 2005. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293: 3012–3021.
-
17.
Le Moing V, Alla F, Doco-Lecompte T, Delahaye F, Piroth L, Chirouze C, Tattevin P, Lavigne JP, Erpelding ML, Hoen B, Vandenesch F, Duval XVIRSTA Study Group, 2015. Staphylococcus aureus bloodstream infection and endocarditis: a prospective cohort study. PLoS One 10: e0127385.
-
18.
Cabell CH, Abrutyn E, 2002. Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am 16: 255–272 vii.
-
19.
Letaief A, Boughzala E, Kaabia N, Ernez S, Abid F, Ben Chaabane T, Ben Jemaa M, Boujnah R, Chakroun M, Daoud M, Gaha R, Kafsi N, Khalfallah A, Slimane L, Zaouali M, 2007. Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis 11: 430–433.
-
20.
Nkomo VT, 2007. Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart 93: 1510–1519.
-
21.
Nunes MC, Gelape CL, Ferrari TC, 2010. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis 14: e394–e398.
-
22.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR, 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30: 633–638.
-
23.
Bach JF, Chalons S, Forier E, Elana G, Jouanelle J, Kayemba S, Delbois D, Mosser A, Saint-Aime C, Berchel C, 1996. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 347: 644–648.
-
24.
Garcia-Granja PE, Lopez J, Vilacosta I, Ortiz-Bautista C, Sevilla T, Olmos C, Sarriá C, Ferrera C, Gómez I, Román JA, 2015. Polymicrobial infective endocarditis: clinical features and prognosis. Medicine (Baltimore) 94: e2000.
-
25.
Coard KC, Skeete DH, 2003. Infective endocarditis at the University Hospital of the West Indies. A revisit. West Indian Med J 52: 235–239.
-
26.
Grangier C, Debin M, Ardillon V, Mahamat A, Fournier PE, Simonnet C, Guillot G, Louvel D, Ravachol F, Perenhou V, Queuche F, Legrand E, Djossou F, Quénel P, Morvan J, Meynard JB, 2009. Epidémiologie de la fièvre Q en Guyane, 1990–2006. Bulletin de Veille Sanitaire n°10 2009: 2–4.
-
27.
Edouard S, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D, 2014. Comparison between emerging Q fever in French Guiana and endemic Q fever in Marseille, France. Am J Trop Med Hyg 90: 915–919.
-
28.
Eldin C, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D, 2014. Q fever in French Guiana. Am J Trop Med Hyg 91: 771–776.
-
29.
da Costa PS, Brigatte ME, Greco DB, 2005. Antibodies to Rickettsia rickettsii, Rickettsia typhi, Coxiella burnetii, Bartonella henselae, Bartonella quintana, and Ehrlichia chaffeensis among healthy population in Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 100: 853–859.
-
30.
Lamas CC, Mares-Guia MA, Rozental T, Moreira N, Favacho AR, Barreira J, Guterres A, Bóia MN, de Lemos ER, 2010. Bartonella spp. infection in HIV positive individuals, their pets and ectoparasites in Rio de Janeiro, Brazil: serological and molecular study. Acta Trop 115: 137–141.
-
31.
Frankel D, Richet H, Renvoise A, Raoult D, 2011. Q fever in France, 1985–2009. Emerg Infect Dis 17: 350–356.
-
32.
Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, Branger S, Gouriet F, Imbert G, Bothello E, Collart F, Habib G, 2005. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43: 5238–5242.
-
33.
Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W, 2001. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 32: 50–62.
-
34.
Bhatti S, Vilenski L, Tight R, Smego RA Jr, 2005. Histoplasma endocarditis: clinical and mycologic features and outcomes. J Infect 51: 2–9.
-
35.
Kauffman CA, 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115–132.
-
36.
Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH, 2007. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 44: 364–372.
-
37.
Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM, 2007. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 115: 1721–1728.
-
38.
Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A, 2011. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 306: 2239–2247.
-
39.
Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW, 2012. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366: 2466–2473.
-
40.
Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, Poyart C, Alla F, Cambau E, Tattevin P, Chirouze C, Obadia JF, Duval X, Hoen BAEPEI Study Group, 2016. Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37: 840–848.
-
41.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Reviewers Document, Erol Ç, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM, 2015. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 36: 3075–3128.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 419 | 272 | 15 |
| Full Text Views | 413 | 9 | 0 |
| PDF Downloads | 96 | 12 | 0 |